Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Alex Schepart

3PUBLICATIONS

12CO-AUTHORS

Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Feb 28, 2024

Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma.

Luciano J Costa, Thomas W LeBlanc, Hans Tesch

|Feb 13, 2024

A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma.

Isha Mol, Yannan Hu, Thomas W LeBlanc

|Dec 11, 2023

A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma.

Isha Mol, Yannan Hu, Thomas W LeBlanc

Pageof 1

Frequent Collaborators

3 joint publications

Thomas W LeBlanc

2 joint publications

Isha Mol

2 joint publications

Haitao Chu

1 joint publications

Luciano J Costa

1 joint publications

Hans Tesch

1 joint publications

Pieter Sonneveld

1 joint publications

Ryan P Kyle

1 joint publications

Liliya Sinyavskaya

1 joint publications

Patrick Hlavacek

1 joint publications

Aster Meche

Frequent Collaborators

3 joint publications

Thomas W LeBlanc

2 joint publications

Isha Mol

2 joint publications

Haitao Chu

1 joint publications

Luciano J Costa

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on : May 04, 2017

See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

<em>In Vitro</em> Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on : May 04, 2017

See more related videos